Pharmaceutical Lipid-Based Excipients Market Report 2026

Pharmaceutical Lipid-Based Excipients Market Overview

• Pharmaceutical Lipid-global-market-report" target="_blank">Lipid-Based Excipients market size has reached to $1.77 billion in 2025 • Expected to grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Rise In Gene Therapy Driving Growth Of Market Due To Increasing Demand For Efficient Genetic Material Delivery • Market Trend: Gattefossé Expands In Asia With Advanced Pharmaceutical Excipients Facility • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Lipid-Based Excipients Market?

Pharmaceutical lipid-based excipients are non-active (inactive) substances derived from lipids used in drug formulations to help deliver, stabilize, or enhance the absorption of the active pharmaceutical ingredient (API). Pharmaceutical lipid-based excipients aim to improve drug solubility, stability, and bioavailability, particularly for poorly water-soluble drugs. The main types of pharmaceutical lipid-based excipients are oils, hydrogenated vegetable oils, glyceryl mono caprylate/caprate (GMCC), hard fats, medium-chain triglycerides, lecithin and phospholipids, sodium oleate, caprylic mono- and diglycerides, and others. Oils function as non-aqueous carriers that enhance the solubility of lipophilic drugs and improve their oral bioavailability. These excipients are applied across various product formulations such as oral, parenteral, topical, ophthalmic applications, suppositories and others. They are used to treat a wide range of disease conditions including cardiovascular diseases, neurological disorders, cancer, metabolic disorders, hormonal imbalances, infectious diseases, and others. Lipid-based excipients are formulated for all age groups pediatric (0–18 years), adult (19–64 years), and geriatric (65+ years). The primary end users include pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and others.

What Is The Pharmaceutical Lipid-Based Excipients Market Growth Forecast?

The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growth in complex drug formulations, increasing demand for enhanced drug absorption, expansion of biologics and oncology drugs, advancements in lipid technologies, rising focus on patient-centric formulations. Major trends in the forecast period include increasing use of lipid excipients for poorly soluble drugs, growing adoption in oral and parenteral formulations, rising demand for bioavailability-enhancing excipients, expansion of lipid-based drug delivery systems, increasing focus on natural and sustainable lipids.

Global Pharmaceutical Lipid-Based Excipients Market Segmentation

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types 2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications 3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications 4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years) 5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users Subsegments: 1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils 2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils 3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC 4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats 5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs 6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids 7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate 8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides 9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

What Is The Driver Of The Pharmaceutical Lipid-Based Excipients Market?

The rise in gene therapy is expected to propel the growth of the pharmaceutical lipid-based excipients market going forward. Gene therapy is a medical technique that involves modifying or manipulating a person's genes to treat or prevent disease. The rise in gene therapy is due to advancements in delivery systems, as they enable safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by enabling efficient delivery systems, ensuring stability and targeted transport of genetic material. They improve therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, advancing the effectiveness of modern treatments. For instance, in December 2024, according to American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved 6 gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the pharmaceutical lipid-based excipients industry.

Key Players In The Global Pharmaceutical Lipid-Based Excipients Market

Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Global Pharmaceutical Lipid-Based Excipients Market Trends and Insights

Major companies operating in the pharmaceutical lipid-based excipients market are focusing on investments such as a strategic investment to develop an advanced Center of Excellence to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive position in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai to support India's growing pharma market, offering specialized labs and tailored support for excipient innovation, with a focus on bioavailability, sustained release, and topical formulations, while strengthening its presence in the Asia-Pacific region. The state-of-the-art facility encompasses pharmaceutical and personal care application laboratories to foster innovation, encourage collaboration, and provide a productive work environment.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Lipid-Based Excipients Market?

In June 2024, CordenPharma, a Switzerland-based pharmaceutical company partnered with Certest Biotec S.L. This partnership aims to integrate Certest's proprietary ionizable lipids into CordenPharma’s LNP formulation services, nhancing RNA/DNA therapeutic development through combined expertise in lipid innovation, manufacturing, and regulation. Certest Biotec S.L. is a Spain-based biotechnology company specializing in drug delivery through lipid nanoparticles (LNPs) and active pharmaceutical ingredient (API) synthesis.

Regional Insights

Europe was the largest region in the pharmaceutical lipid-based excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Lipid-Based Excipients Market?

The pharmaceutical lipid-based excipients market consists of sales of lipid excipients, specialty formulations, sterols, waxes, and glycolipids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Lipid-Based Excipients Market Report 2026?

The pharmaceutical lipid-based excipients market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical lipid-based excipients industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.